TL;DR
Researchers have designed and synthesized a new class of carbamate compounds that selectively target the M1 muscarinic acetylcholine receptor (mAChR). These compounds show promising affinity and selectivity, with potential applications as PET imaging agents for neurological disorders.
What Problem Does This Paper Address?
Muscarinic acetylcholine receptors (mAChRs) are crucial for various physiological functions, particularly in the central nervous system (CNS). They are implicated in numerous neurological and psychiatric disorders, making them attractive therapeutic targets. However, developing subtype-selective ligands for mAChRs has been a significant challenge due to the high similarity among the five receptor subtypes (M1-M5), especially in their orthosteric binding sites. This lack of selectivity often leads to dose-limiting side effects when using non-selective drugs. The authors aim to address this by identifying novel, subtype-selective M1 mAChR antagonists that could serve as PET imaging probes for better understanding and diagnosing neurological conditions.
Methods
The study employed a multi-faceted approach:
- In Silico Ligand Design: A rigorous molecular docking campaign was performed against the crystal structure of the M1 muscarinic receptor (PDB 5CXV). This involved screening a large library of commercially available diamines, filtering them based on structural criteria (cyclic tertiary N-methyl amine), and then linking them to a 4,4'-difluorobenzhydrol moiety via a carbamate bridge. A key filtering step involved ensuring the protonated amine of the ligand could form an ionic interaction with Asp1053.32, a conserved residue in GPCRs.
- Synthesis: Twelve promising compounds identified from the docking study were synthesized using a general procedure involving the reaction of primary or secondary amines with N,N'-carbonyldiimidazole (CDI) followed by treatment with the sodium alkoxide of 4,4'-difluorobenzhydrol.
- Physico-Chemical Property Evaluation: The synthesized compounds were characterized for properties relevant to CNS penetration and potential for reduced non-displaceable binding (NDB), including HPLC-logD (lipophilicity), tPSA (total polar surface area), logBB (brain-to-plasma partition coefficient), and logPS (brain penetration rate).
- Biological Evaluation:
- Radioligand Binding Assays: Competitive binding experiments were conducted using Chinese hamster ovary (CHO) cell membranes expressing individual human mAChR subtypes (hM1-hM5) to determine the affinity (Ki) and subtype selectivity of the synthesized compounds. [3H]NMS was used as the radioligand.
- Calcium Mobilization Assay: A Fluo-4 Direct™ assay was used to assess the functional activity of the compounds, determining whether they acted as agonists or antagonists by measuring intracellular calcium flux in response to stimulation with a known agonist (carbachol).
Datasets
- In Silico Screening Library: A library of 52,857 amines was curated from commercially available databases (Enamine and Chemspace).
- Protein Data Bank (PDB): The crystal structure of the M1 muscarinic acetylcholine receptor (PDB ID: 5CXV) was used for molecular docking.
- CHO-hM1-5 Cell Lines: Stably transfected Chinese hamster ovary (CHO-K1) cells expressing human M1-M5 muscarinic acetylcholine receptors were used for biological assays.
Key Insights and Ideas
- Carbamate Linkage as a Promising Scaffold: The carbamate linkage proved effective in connecting the 4,4'-difluorobenzhydrol moiety with various cyclic diamines, leading to compounds with good affinity and selectivity for the M1 receptor.
- Structural Rigidity and Selectivity: The authors hypothesized that structural rigidification of the amine part of the molecule could lead to increased binding affinity. The use of cyclic amines in their library design likely contributed to achieving better selectivity.
- Potential for PET Imaging: The physico-chemical properties of the synthesized compounds, particularly their predicted BBB permeability (indicated by HPLC-logD, logBB, and logPS values), suggest their suitability for developing PET imaging tracers.
- Antagonistic Activity is Advantageous for PET: The finding that all tested compounds acted as antagonists is highlighted as a potential advantage for PET imaging, as it may reduce the risk of unwanted pharmacological effects and ligand-induced conformational changes.
- Structure-Activity Relationship (SAR) Hints: While not extensively detailed, the paper suggests that subtle structural modifications can significantly impact binding affinities and selectivity, paving the way for further optimization.
Key Results
- Compound 2 as a Lead Candidate: Compound 2, a 1,4-diazepane derivative, exhibited the highest affinity for the hM1R with a Ki of 1.2 nM. It also demonstrated good-to-excellent selectivity against hM2-4R (up to 189-fold) and moderate selectivity against hM5R (4-fold).
- Promising Selectivity Profile: Compounds 2, 5, and 7 were identified as particularly promising due to their favorable affinity, subtype selectivity, and physico-chemical properties.
- BBB Permeability: All synthesized carbamates showed HPLC-logD values within the range indicative of potential BBB permeation, with most also meeting established criteria for logBB and logPS.
- Antagonistic Action: All 12 tested compounds demonstrated dose-dependent antagonistic activity at the hM1R, as confirmed by calcium mobilization assays.
- Stability: Compounds 3 and 7 showed good stability in cell culture media for up to 24 hours, which is adequate for PET tracer development.
Limitations and Future Work
- Racemic Mixtures: For some compounds, racemic mixtures were used for initial testing, and further studies are planned to investigate the enantiomer-specific affinity and selectivity profiles of compounds like 7.
- Further Optimization: While compounds 2, 5, and 7 are promising, further optimization may be needed to enhance selectivity and affinity for specific applications.
- In Vivo Studies: The paper suggests that compounds 2, 5, and 7 are candidates for future PET tracer development, implying that in vivo studies will be the next logical step.
- Understanding Enantiomer-Specific Profiles: The authors explicitly state that studies are underway to better understand the enantioselective affinity and selectivity profiles of the enantiomers of compound 7.
Summary updated